Showing 501 - 520 results of 14,525 for search '"opioid"', query time: 0.24s Refine Results
  1. 501
  2. 502

    3142 U.S. Counties with High Opioid-Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder: an Observational Study by Rebecca Haffajee, Lewei Allison Lin, Amy S.B. Bohnert, Jason E. Goldstick

    Published 2019-03-01
    “…OBJECTIVES/SPECIFIC AIMS: To identify characteristics of counties with persistently high opioid-overdose rates and low capacity to deliver medications for OUD (MOUD). …”
    Get full text
    Article
  3. 503

    Opioid/Dopamine Receptor Binding Studies, NMR and Molecular Dynamics Simulation of LENART01 Chimera, an Opioid-Bombesin-like Peptide by Pawel Serafin, Łukasz Szeleszczuk, Igor Zhukov, Edina Szűcs, Dávid Gombos, Azzurra Stefanucci, Adriano Mollica, Dariusz Maciej Pisklak, Patrycja Kleczkowska

    Published 2024-01-01
    “…Since dopamine receptors have been implicated in the aforementioned adverse effects of opioids, the construction of a hybrid with dual action at opioid and dopamine receptors is of interest. …”
    Get full text
    Article
  4. 504
  5. 505
  6. 506
  7. 507
  8. 508
  9. 509
  10. 510
  11. 511
  12. 512

    Behavioral intervention to reduce opioid overdose among high-risk persons with opioid use disorder: A pilot randomized controlled trial. by Phillip Oliver Coffin, Glenn-Milo Santos, Tim Matheson, Emily Behar, Chris Rowe, Talia Rubin, Janelle Silvis, Eric Vittinghoff

    Published 2017-01-01
    “…The United States is amidst an opioid epidemic, including synthetic opioids that may result in rapid death, leaving minimal opportunity for bystander rescue. …”
    Get full text
    Article
  13. 513
  14. 514

    The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer. by Frances E Lennon, Tamara Mirzapoiazova, Bolot Mambetsariev, Valeriy A Poroyko, Ravi Salgia, Jonathan Moss, Patrick A Singleton

    Published 2014-01-01
    “…Recent epidemiologic studies implying differences in cancer recurrence based on anesthetic regimens raise the possibility that the mu opioid receptor (MOR) can influence cancer progression. …”
    Get full text
    Article
  15. 515

    The efficacy of prophylactic prochlorperazine injections at the initiation of opioid injections in preventing opioid-induced nausea and vomiting among patients with end-stage cancer by Kazuki Imai, Akihiko Futamura, Miyo Murai, Akihiro Ito, Norimasa Tsuzuki, Masanobu Usui

    Published 2023-11-01
    “…Methods: Patients with end-stage cancer who received opioid injections for more than 5 days between April 2017 and March 2020 were classified into two groups: the opioid and prochlorperazine injection group and opioid alone group. …”
    Get full text
    Article
  16. 516
  17. 517
  18. 518
  19. 519
  20. 520

    Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis by Donahue Renee N, Conway Andrea, Park Sunny S, Zagon Ian S, McLaughlin Patricia J, Goldenberg David

    Published 2009-10-01
    “…The growth characteristics in the presence of OGF or the opioid antagonist naltrexone (NTX), and the specificity of opioid peptides for proliferation of ATC, were established in KAT-18 cells. …”
    Get full text
    Article